Hemab ApS: Clinical Trials

3 trials sponsored by Hemab ApS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Active not recruiting 1
Phase 12Active not recruiting 1, Recruiting 1

Follow Hemab ApS: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency
Sutacimig - Congenital Factor VII Deficiency
Phase 2RecruitingHemab ApS182026-03-112026-07-22
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
HMB-002 (Part A), HMB-002 (Part B), HMB-002 with Concomitant Factor Concentrate (Part C) (Not Applicable in US) - Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1
Phase 1 / Phase 2RecruitingHemab ApS1082025-02-062026-06-30
A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
HMB-001 - Glanzmann Thrombasthenia
Phase 1 / Phase 2Active not recruitingHemab ApS572022-12-132026-09-25

Conditions studied

Factor VII Deficiency (1)  ·  Thrombasthenia (1)  ·  von Willebrand Disease, Type 3 (1)  ·  von Willebrand Diseases (1)

Countries

United Kingdom (3)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)